Silverback Therapeutics logo
Silverback Therapeutics SBTX
$ 6.1 4.99%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Silverback Therapeutics ROCE Ratio 2011-2024 | SBTX

Annual ROCE Ratio Silverback Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-29.26 -13.01 62.21 -8.55 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
62.21 -29.26 2.85

Quarterly ROCE Ratio Silverback Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-31.42 -28.17 -29.34 -23.03 -9.81 10.98 33.68 46.18 39.35 19.31 -2.11 -18.96 -21.08 -16.37 -11.05 -5.18 -5.18 -3.06 -1.37 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
46.18 -31.42 -2.98